Roland Baron

Advisor at Ankasa Regenerative Therapeutics

Dr. Roland Baron is Professor in the department of Medicine at the Harvard Medical School (Boston, USA) and Endocrine Unit, Massachusetts General Hospital, and Professor and Chair of the department of Oral Medicine, Infection and Immunity at the Harvard School of Dental Medicine, Head of the Division of Bone and Mineral Research, since January 2008. Between 1977 and 2007 Dr. Baron was a Professor in the departments of Medicine, Orthopaedics and Cell Biology at Yale University School of Medicine (New Haven, USA). He received his DMD and PhD degrees from the University of Paris, France. He is the founder and past Editor-in-Chief of Bone. Between 1994 and 2002, he also held the position of Vice-President and Head of the Bone Diseases Group at Hoechst Marion Roussel and then Aventis. In 2002 he founded ProSkelia, a small pharmaceutical company devoted to the discovery and development of new drugs for bone and hormonal dependent diseases. He held the positions of President and Chief Scientific Officer of ProSkelia and then ProStrakan, through April 2006. From 2015 to 2019, Dr. Baron was on the Board of Directors of Bone Therapeutics in Belgium, a company devoted to cell therapy for bone regeneration. From 2006 to the present, Dr. Baron has been on several scientific or global advisory boards of pharmaceutical and biotech companies, including the

SAB of Ankasa Regenerative Therapeutics since 2015. Dr. Baron has been President of the European Calcified Tissue Society (ECTS, 2007-10) and President of the American Society for Bone and Mineral Research (ASBMR, 2014-15), and is presently co-Chair of the International Federation of Musculoskeletal Research Societies (IFMRS, since 2015). Dr. Baron has received several prestigious awards for his contributions, including the Louis Avioli Founders Award and the William F. Neuman awards from ASBMR, the Harold Copp award from the IBMS and the Excellence in Research award from the ECTS. He has published over 370 scientific papers in the field of bone biology and bone diseases.

Timeline

  • Advisor

    Current role